💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueSee Undervalued Stocks

EU govts working hard on Recovery Plan, any difficulties will be seen at end: Von der Leyen to paper

Published 02/02/2021, 01:50 AM
Updated 02/02/2021, 01:55 AM
© Reuters. Videoconference of EU leaders to discuss COVID-19
AZN
-
PFE
-
MRNA
-

MILAN (Reuters) - European governments are working hard on the Recovery Plan and any difficulties will be seen at the end, the president of the European Commission said on Tuesday, when asked whether she was worried about possible delays due to Italy's political crisis.

"I expect that member states ratify the Recovery Plan in time because it is in their interest to do so so that the Commission can go to the markets to collect the money," Ursula von der Leyen told daily la Repubblica in an interview.

Von der Leyen added that Astrazeneca (LON:AZN) would provide 40 million doses of anti-COVID vaccines in Europe in the coming two months and "we expect it will make up for cuts seen in first quarter".

© Reuters. Videoconference of EU leaders to discuss COVID-19

She also confirmed the target to vaccinate 70% of Europe's adult population by the summer, adding that 300 million doses of Pfizer (NYSE:PFE), Moderna (NASDAQ:MRNA) and Astrazeneca vaccines were coming in the second quarter and, if approved, further 80 million vials from Johnson&Johnson and Curevac.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.